Olaparib and Bevacizumab in Relapsed Small Cell Lung Cancer Subjects
Clinical trial NCT04939662 · COMPLETED
Trial details
- NCT number
- NCT04939662
- Sponsor
- Se-Hoon Lee
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2023-10-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.